• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两例 Gitelman 综合征家系合并蛋白尿或桥本甲状腺炎的临床分析及复合杂合突变研究

Review and Analysis of Two Gitelman Syndrome Pedigrees Complicated with Proteinuria or Hashimoto's Thyroiditis Caused by Compound Heterozygous Mutations.

机构信息

Shengli Clinical Medical College of Fujian Medical University, Fuzhou 350001, China.

Fujian Provincial Hospital, Fuzhou 350001, China.

出版信息

Biomed Res Int. 2021 May 10;2021:9973161. doi: 10.1155/2021/9973161. eCollection 2021.

DOI:10.1155/2021/9973161
PMID:34046503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8128541/
Abstract

Gitelman syndrome (GS) is an autosomal recessive inherited salt-losing renal tubular disease, which is caused by a pathogenic mutation of encoding thiazide-sensitive Na-Cl cotransporter, which leads to disturbance of sodium and chlorine reabsorption in renal distal convoluted tubules, resulting in phenotypes such as hypovolemia, renin angiotensin aldosterone system (RAAS) activation, hypokalemia, and metabolic alkalosis. In this study, two GS families with proteinuria or Hashimoto's thyroiditis were analyzed for genetic-phenotypic association. Sanger sequencing revealed that two probands carried compound heterozygous mutations, and proband A carried two pathogenic mutations: missense mutation Arg83Gln, splicing mutation, or frameshift mutation NC_000016.10:g.56872655_56872667 (gcggacatttttg>accgaaaatttt) in exon 8. Proband B carries two missense mutations: novel Asp839Val and Arg904Gln. Both probands manifested hypokalemia, hypomagnesemia, hypocalcinuria, metabolic alkalosis, and RAAS activation; in addition, the proband A exhibited decreased urinary chloride, phosphorus, and increased magnesium ions excretion, complicated with Hashimoto's Thyroiditis, while the proband B exhibited enhanced urine sodium excretion and proteinuria. The older sister of proband B with GS also had Hashimoto's thyroiditis. Electron microscopy revealed swelling and vacuolar degeneration of glomerular epithelial cells, diffuse proliferation of mesangial cells and matrix, accompanied by a small amount of low-density electron-dense deposition, and segmental fusion of epithelial cell foot processes in proband B. Light microscopy showed mild mesangial hyperplasia in the focal segment of the glomerulus, hyperplasia, and hypertrophy of juxtaglomerular apparatus cells, mild renal tubulointerstitial lesions, and one glomerular sclerosis. So, long-term hypokalemia of GS can cause kidney damage and may also be susceptible to thyroid disease.

摘要

格利森综合征(GS)是一种常染色体隐性遗传性失盐性肾小管疾病,由编码噻嗪敏感的钠-氯共转运体的致病突变引起,导致肾远曲小管钠和氯重吸收紊乱,表现为低血容量、肾素-血管紧张素-醛固酮系统(RAAS)激活、低钾血症和代谢性碱中毒等表型。本研究分析了两例伴有蛋白尿或桥本甲状腺炎的 GS 家系的遗传表型相关性。Sanger 测序显示,两名先证者均携带复合杂合突变,先证者 A 携带两个致病性突变:错义突变 Arg83Gln,剪接突变或移码突变 NC_000016.10:g.56872655_56872667(gcggacatttttg>accgaaaatttt)在 8 号外显子。先证者 B 携带两个错义突变:新的 Asp839Val 和 Arg904Gln。两名先证者均表现为低钾血症、低镁血症、低钙尿症、代谢性碱中毒和 RAAS 激活;此外,先证者 A 还表现为尿氯、磷减少,镁离子排泄增加,伴有桥本甲状腺炎,而先证者 B 表现为尿钠排泄增加和蛋白尿。先证者 B 的 GS 姐姐也患有桥本甲状腺炎。电镜下,先证者 B 的肾小球上皮细胞肿胀,空泡变性,系膜细胞和基质弥漫增生,伴有少量低密度电子致密物沉积,上皮细胞足突节段融合。光镜下,肾小球局灶节段性系膜细胞轻度增生,肾小球旁器细胞增生、肥大,轻度肾小管间质病变,1 个肾小球硬化。因此,GS 的长期低钾血症可导致肾脏损害,也可能易患甲状腺疾病。

相似文献

1
Review and Analysis of Two Gitelman Syndrome Pedigrees Complicated with Proteinuria or Hashimoto's Thyroiditis Caused by Compound Heterozygous Mutations.两例 Gitelman 综合征家系合并蛋白尿或桥本甲状腺炎的临床分析及复合杂合突变研究
Biomed Res Int. 2021 May 10;2021:9973161. doi: 10.1155/2021/9973161. eCollection 2021.
2
Identification of compound mutations of SLC12A3 gene in a Chinese pedigree with Gitelman syndrome exhibiting Bartter syndrome-liked phenotypes.鉴定一个中国 Gitelman 综合征家系中 SLC12A3 基因突变的复合杂合子,该家系表现出 Bartter 综合征样表型。
BMC Nephrol. 2020 Aug 5;21(1):328. doi: 10.1186/s12882-020-01996-2.
3
A pedigree analysis of two homozygous mutant Gitelman syndrome cases.两例纯合突变型吉特曼综合征病例的系谱分析
Endocr J. 2015;62(1):29-36. doi: 10.1507/endocrj.EJ14-0289. Epub 2014 Oct 2.
4
A NOVEL COMPOUND HETEROZYGOUS VARIANT OF SLC12A3 GENE IN A PEDIGREE WITH GITELMAN SYNDROME CO-EXISTENT WITH THYROID DYSFUNCTION.一个家系中存在 SLC12A3 基因突变的吉特曼综合征伴甲状腺功能紊乱
Endocr Pract. 2018 Oct 2;24(10):889-893. doi: 10.4158/EP-2018-0218. Epub 2018 Aug 7.
5
A novel compound heterozygous mutation of SLC12A3 gene in a pedigree with Gitelman syndrome and literature review.一个 Gitelman 综合征家系中 SLC12A3 基因的新型复合杂合突变及文献复习。
Genes Genomics. 2020 Sep;42(9):1035-1040. doi: 10.1007/s13258-020-00960-6. Epub 2020 Jul 25.
6
A novel compound heterozygous variant of the SLC12A3 gene in Gitelman syndrome pedigree.吉特曼综合征家系中SLC12A3基因的一种新型复合杂合变异体。
BMC Med Genet. 2018 Jan 29;19(1):17. doi: 10.1186/s12881-018-0527-7.
7
A case of hypokalemia and proteinuria with a new mutation in the SLC12A3 Gene.一例伴有SLC12A3基因新突变的低钾血症和蛋白尿病例。
BMC Nephrol. 2018 Oct 19;19(1):275. doi: 10.1186/s12882-018-1083-2.
8
Gitelman syndrome and glomerular proteinuria: a link between loss of sodium-chloride cotransporter and podocyte dysfunction?吉特曼综合征与肾小球蛋白尿:氯化钠共转运体缺失与足细胞功能障碍之间的联系?
Nephrol Dial Transplant. 2014 Sep;29 Suppl 4:iv117-20. doi: 10.1093/ndt/gfu075.
9
Gitelman syndrome with Graves' disease leading to rhabdomyolysis: a case report and literature review.Gitelman 综合征合并 Graves 病致横纹肌溶解症 1 例报告并文献复习
BMC Nephrol. 2023 May 2;24(1):123. doi: 10.1186/s12882-023-03180-8.
10
Gitelman syndrome in a South African family presenting with hypokalaemia and unusual food cravings.一个南非家庭中出现低钾血症和异常食物渴望的吉特曼综合征。
BMC Nephrol. 2017 Jan 26;18(1):38. doi: 10.1186/s12882-017-0455-3.

引用本文的文献

1
The role of SLC12A3 gene variant c.1964G > A in co-existing Gitelman syndrome and unilateral limb paralysis: a case report and literature review.SLC12A3基因变异c.1964G > A在并存吉特曼综合征和单侧肢体麻痹中的作用:一例报告及文献综述
BMC Nephrol. 2025 Mar 26;26(1):153. doi: 10.1186/s12882-025-04075-6.
2
A novel homozygous SLC12A3 mutation causing Gitelman syndrome with co-existent autoimmune thyroiditis: a case report and review of the literature.一个新的 SLC12A3 基因突变导致 Gitelman 综合征合并自身免疫性甲状腺炎:病例报告及文献复习。
CEN Case Rep. 2024 Oct;13(5):330-338. doi: 10.1007/s13730-023-00845-z. Epub 2024 Feb 3.
3

本文引用的文献

1
Arg913Gln variation of SLC12A3 gene is associated with diabetic nephropathy in type 2 diabetes and Gitelman syndrome: a systematic review.SLC12A3 基因 Arg913Gln 变异与 2 型糖尿病和 Gitelman 综合征的糖尿病肾病有关:系统评价。
BMC Nephrol. 2019 Oct 28;20(1):393. doi: 10.1186/s12882-019-1590-9.
2
Genetic Analysis of SLC12A3 Gene in Chinese Patients with Gitelman Syndrome.SLC12A3 基因在中国 Gitelman 综合征患者中的遗传分析。
Med Sci Monit. 2019 Aug 9;25:5942-5952. doi: 10.12659/MSM.916069.
3
Complicated Gitelman syndrome and autoimmune thyroid disease: a case report with a new homozygous mutation in the SLC12A3 gene and literature review.
Gitelman syndrome with Graves' disease leading to rhabdomyolysis: a case report and literature review.
Gitelman 综合征合并 Graves 病致横纹肌溶解症 1 例报告并文献复习
BMC Nephrol. 2023 May 2;24(1):123. doi: 10.1186/s12882-023-03180-8.
4
Clinicopathological Features of Gitelman Syndrome with Proteinuria and Renal Dysfunction.伴蛋白尿和肾功能障碍的 Gitelman 综合征的临床病理特征。
Nephron. 2023;147(9):531-540. doi: 10.1159/000529775. Epub 2023 Feb 20.
5
Novel compound heterozygous mutation of in Gitelman syndrome co-existent with hyperthyroidism: A case report and literature review.吉特曼综合征中新型复合杂合突变与甲状腺功能亢进并存:一例报告及文献复习
World J Clin Cases. 2022 Jul 26;10(21):7483-7494. doi: 10.12998/wjcc.v10.i21.7483.
复杂型 Gitelman 综合征合并自身免疫性甲状腺疾病:一例新的 SLC12A3 基因突变纯合子病例报告及文献复习。
BMC Endocr Disord. 2018 Nov 8;18(1):82. doi: 10.1186/s12902-018-0298-3.
4
Hypokalemia: a clinical update.低钾血症:临床最新进展
Endocr Connect. 2018 Apr;7(4):R135-R146. doi: 10.1530/EC-18-0109. Epub 2018 Mar 14.
5
Recognizing thyrotoxic hypokalemic periodic paralysis.认识甲状腺毒症性低钾性周期性麻痹。
JAAPA. 2018 Jan;31(1):31-34. doi: 10.1097/01.JAA.0000527697.21783.5a.
6
[Expert consensus for the diagnosis and treatment of patients with Gitelman syndrome].[吉特林综合征患者诊断与治疗专家共识]
Zhonghua Nei Ke Za Zhi. 2017 Sep 1;56(9):712-716. doi: 10.3760/cma.j.issn.0578-1426.2017.09.021.
7
Arg913Gln of SLC12A3 gene promotes development and progression of end-stage renal disease in Chinese type 2 diabetes mellitus.SLC12A3 基因 Arg913Gln 促进中国 2 型糖尿病终末期肾病的发生发展。
Mol Cell Biochem. 2018 Jan;437(1-2):203-210. doi: 10.1007/s11010-017-3120-z. Epub 2017 Jul 25.
8
Increased urinary prostaglandin E2 metabolite: A potential therapeutic target of Gitelman syndrome.尿中前列腺素E2代谢产物增加:吉特曼综合征的一个潜在治疗靶点。
PLoS One. 2017 Jul 10;12(7):e0180811. doi: 10.1371/journal.pone.0180811. eCollection 2017.
9
[Clinical and genetic characteristics of Gitelman syndrome in 5 pedigrees].5个家系吉特林综合征的临床及遗传学特征
Zhonghua Nei Ke Za Zhi. 2017 Feb 1;56(2):104-111. doi: 10.3760/cma.j.issn.0578-1426.2017.02.005.
10
Gitelman syndrome: consensus and guidance from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.Gitelman 综合征:改善全球肾脏病预后组织(KDIGO)争议会议的共识和指导意见。
Kidney Int. 2017 Jan;91(1):24-33. doi: 10.1016/j.kint.2016.09.046.